358570 — GI Innovation Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual income statement for GI Innovation, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	11,017	5,600	3,500	5,319	24.3
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	33,891	36,232	71,452	58,623	48,284
Operating Profit	-22,875	-30,632	-67,952	-53,305	-48,260
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-75,933	-150,742	-79,833	-55,022	-59,007
Provision for Income Taxes
Net Income After Taxes	-75,933	-150,742	-79,833	-55,495	-58,784
Net Income Before Extraordinary Items
Net Income	-75,933	-150,742	-79,833	-55,495	-58,784
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-75,933	-150,742	-79,833	-55,495	-58,784
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,437	-2,852	-1,511	-1,071	-1,126
Dividends per Share